Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
about
Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence BaseAprotinin decreases ischemic damage during coronary revascularization.No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding, inflammation, and ischaemia after aortic valve surgery.Aprotinin concentration varies significantly according to cardiopulmonary bypass conditions.Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants.Continuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapyEffects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgeryThe safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgeryModulation of systemic inflammatory response after cardiac surgery.Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.Safety aspects of aprotinin therapy in cardiac surgery patients.Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass.RECCAS - REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial.Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot studyAspects of bleeding after cardiac surgery in children.Human plasma kallikrein-kinin system: physiological and biochemical parametersBenefits and risks of aprotinin use during cardiac surgery.Aprotinin exacerbates left ventricular dysfunction after ischemia/reperfusion in mice lacking tumor necrosis factor receptor I.Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass.Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.Intraoperative platelet transfusion is associated with increased postoperative sternal wound infections among type A aortic dissection patients after total arch replacement.Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.Antifibrinolytic agents: aprotinin, and desmopressin.Biochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor.Aortic valve replacement in a dialysis-dependent Jehovah's Witness: successful use of a minicircuit, microplegia, and multimodality blood conservation technique.Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced acute injury in mice.Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats.Efficacy of a high-dose aprotinin regimen for reducing transfusion requirements and inflammatory responses in adult cardiac surgery.Development of post-pump syndrome in a sheep after mitral valve stenting.The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection.Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced chronic injury in rats.High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience.Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside.Antifibrinolytic Therapy and Perioperative Considerations.Polymer-coated cardiopulmonary bypass circuit attenuates upregulation of both proteases/protease inhibitors and platelet degranulation in pigs.Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
P2860
Q26781711-D17FBF5F-CC2A-447D-9B02-B624A93F06ACQ33227865-0639789A-DDE2-4ACE-9AF4-BB497AEA2F63Q33668193-CDC7EE0C-5A72-4590-B332-31E077234415Q33837089-CCB785F8-CA8B-434D-871B-551C574C4AC9Q34274138-E57B1327-02E4-4195-81F2-542605A78FBDQ34820663-A0889F87-B506-4F4D-9051-2E404298D517Q34999581-D622CAAD-E6A5-4F7D-8A6C-AF5E9E773D72Q35587102-D18E8610-5FFE-4145-8B7A-79F44688BA5FQ36320195-2AB4F4C1-A102-4611-BA81-CBC979E780DFQ36375918-DB1E7404-E190-4A61-8BCD-EBA2BA896F01Q36506820-F71B145A-DED0-4668-8FE6-F4C141C3BF21Q36521995-62F3886D-841C-4D83-878E-F64333E0C0E8Q36526980-6809E7F7-777A-434F-ADAF-B7D1B2DC726CQ36642661-9F5746C7-6957-48B0-874C-421161C994E2Q36680489-C7C15298-527E-4CFC-A169-208BA2A2B0DBQ36939565-B74F7C8F-D497-4250-8CC0-1B51F9C1A03DQ36994497-8F920569-896F-40CE-BB2E-616E18313964Q36998879-15EC8128-B47D-4FAC-8E07-1BE41038A7F6Q37043551-106E9592-B926-44E2-9489-50DD00D27146Q37088369-5E276F66-2D73-4FAC-A753-55BB363C13F6Q37151445-75D2A2EA-8651-493F-81C1-C39F451B9225Q37663916-8CED7AC2-D38D-4559-9D36-109639B4F658Q38695903-C6492A14-87AA-4FD1-8793-A8BB727F1714Q41817079-3275C849-3534-4477-8B02-D9D3AEAFB386Q41965869-D69BC86B-482C-4BCB-B4C7-753BA192CBB3Q41982669-5AE27847-ACA0-4DD6-9655-F0159A1A9A2DQ42873206-5849FC6D-BACE-4568-B082-8ADD10E6D3D8Q43058453-BBCC4B12-2BE4-481B-A1AB-ED816589000FQ46083282-2E80E9EE-6A69-47A4-A2A9-60AC65936B1DQ46334560-2EB1EED5-7A42-4D73-B88E-E61872CAE21CQ46377103-9ED08724-7750-4167-AA88-5CFE6890CEF6Q46690444-B166E2D6-7BBE-46A4-B93A-9E39DBB28697Q47435169-D2C40C6D-A13A-46DF-8A3D-A6D853CAE8C4Q48006150-0AEAEF70-2FC7-40A7-A397-139595E36AD7Q48178948-6FED1F8F-4A30-4C10-B37F-5308FA5B83B4Q49966150-34593A1F-64FF-41D6-AA10-DB954016CDD8Q50099821-F28F1C57-AB08-486A-9D08-73399D29FADDQ50848728-28C80A24-4C54-4260-A9E9-9FA8571C1AB5Q56031831-3D3424D5-B6E2-42B6-AEF7-0C8071FA3D90
P2860
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@ast
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@en
type
label
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@ast
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@en
prefLabel
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@ast
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@en
P1476
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
@en
P2093
P304
P356
10.1016/S0003-4975(00)02218-9
P407
P577
2001-02-01T00:00:00Z